Self-Assembled 2D Glycoclusters for the Targeted Delivery of Theranostic Agents to Triple-Negative Breast Cancer Cells
文献类型:期刊论文
作者 | Hu, Xi-Le1,2; Ca, Quanyu4; Gao, Jie1,2,3; Field, Robert A.5; Chen, Guo-Rong1,2; Jia, Ningyang4; Zang, Yi3![]() ![]() |
刊名 | ACS APPLIED MATERIALS & INTERFACES
![]() |
出版日期 | 2019-06-26 |
卷号 | 11期号:25页码:22181-22187 |
关键词 | self-assembly 2D material glycocluster theranostics breast cancer |
ISSN号 | 1944-8244 |
DOI | 10.1021/acsami.9b06016 |
通讯作者 | Jia, Ningyang(ningyangjia@163.com) ; Zang, Yi(yzang@simm.ac.cn) ; Li, Jia(jli@simm.ac.cn) ; He, Xiao-Peng(xphe@ecust.edu.cn) |
英文摘要 | Triple-negative breast cancer (TNBC) is a devastating disease worldwide, for which targeted imaging and therapeutic agents remain elusive. There has been growing awareness that carbohydrates are valuable as drug candidates and targeting agents for a variety of human diseases, including cancers that overexpress carbohydrate receptors on the cell surface. Here, we develop a two-dimensional (2D) glycocluster by means of simple, stepwise self assembly for the targeted delivery of theranostic agents to TNBC cells that express mannose receptors (MRs) on the cell surface. Human serum albumin, which contains a variety of hydrophobic pockets capable of accommodating small molecules, was used to simultaneously encapsulate a mannose-based glycoprobe and a commercial photosensitizer (i.e., Ce6). The multicomponent "neoglycoprotein" formed was used to self-assemble with 2D MnO2, producing 2D glycoclusters, which could be selectively internalized by a TNBC cell line (MDA-MB-231) as facilitated by binding to the transmembrane MR. The intracellular degradation of the 2D MnO2 backbone by biothiols then released Ce6 for cell imaging and, subsequently, photodynamic therapy. This study provides insights into the development of carbohydrate-based materials for targeted, stimuli-responsive theranostics of TNBC. |
WOS关键词 | PHOTODYNAMIC THERAPY ; DRUG-DELIVERY ; IN-VITRO ; ANTICANCER DRUG ; GRAPHENE OXIDE ; GLUTATHIONE ; NANOCOMPOSITES ; CHEMOTHERAPY ; BINDING ; VIVO |
资助项目 | National Natural Science Foundation of China[21722801] ; National Natural Science Foundation of China[21776078] ; National Natural Science Foundation of China[81671739] ; National Natural Science Foundation of China[81673489] ; National Natural Science Foundation of China[81125023] ; Shanghai Municipal Science and Technology Major Project[2018SHZDZX03] ; International Cooperation Project[16430724100] |
WOS研究方向 | Science & Technology - Other Topics ; Materials Science |
语种 | 英语 |
WOS记录号 | WOS:000473251100014 |
出版者 | AMER CHEMICAL SOC |
源URL | [http://119.78.100.183/handle/2S10ELR8/289270] ![]() |
专题 | 新药研究国家重点实验室 |
通讯作者 | Jia, Ningyang; Zang, Yi; Li, Jia; He, Xiao-Peng |
作者单位 | 1.East China Univ Sci & Technol, Sch Chem & Mol Engn, Key Lab Adv Mat, Shanghai 200237, Peoples R China 2.East China Univ Sci & Technol, Sch Chem & Mol Engn, Feringa Nobel Prize Scientist Joint Res Ctr, Shanghai 200237, Peoples R China 3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Natl Ctr Drug Screening, 189 Guo Shoujing Rd, Shanghai 201203, Peoples R China 4.Eastern Hepatobiliary Surg Hosp, Dept Radiol, Shanghai 200438, Peoples R China 5.John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England |
推荐引用方式 GB/T 7714 | Hu, Xi-Le,Ca, Quanyu,Gao, Jie,et al. Self-Assembled 2D Glycoclusters for the Targeted Delivery of Theranostic Agents to Triple-Negative Breast Cancer Cells[J]. ACS APPLIED MATERIALS & INTERFACES,2019,11(25):22181-22187. |
APA | Hu, Xi-Le.,Ca, Quanyu.,Gao, Jie.,Field, Robert A..,Chen, Guo-Rong.,...&He, Xiao-Peng.(2019).Self-Assembled 2D Glycoclusters for the Targeted Delivery of Theranostic Agents to Triple-Negative Breast Cancer Cells.ACS APPLIED MATERIALS & INTERFACES,11(25),22181-22187. |
MLA | Hu, Xi-Le,et al."Self-Assembled 2D Glycoclusters for the Targeted Delivery of Theranostic Agents to Triple-Negative Breast Cancer Cells".ACS APPLIED MATERIALS & INTERFACES 11.25(2019):22181-22187. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。